Penn Medicine

DNA methylation-based classification uncovers acinar and ductal origins for KPC-derived PDAC cell lines (2026) Zoi I, Rajput M, Holguín-Horcajo A, Haidar M, Brusa D, Chu K, Xie J, et al. Journal article Clinical and Molecular Evaluation of HER2-Low and HER2-Ultralow Breast Cancer in the Penelope-B Clinical Trial Cohort (2026) Denkert C, Rachakonda S, Pehl A, Marmé F, Martin M, Karn T, Untch M, et al. Journal article Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment (2026) Biller BM, Casagrande A, Elenkova A, Boguszewski CL, Jallad RS, Hu B, Hubina E, et al. Journal article Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis (2026) Oertel M, Dabaja B, Görlich D, Thomas BR, Sim V, Johnstone P, Hashmi A, et al. Journal article The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD (2025) Akahoshi Y, Portelli J, Katsivelos N, Louloudis IE, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, et al. Journal article Refinement of day 28 treatment response criteria for acute GVHD: a collaboration study of the JSTCT and MAGIC (2025) Akahoshi Y, Inamoto Y, Spyrou N, Nakasone H, Diniz MA, Asada N, Ayuk F, et al. Journal article Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies (2025) Hahnen E, Hauke J, Gelmon K, Marmé F, Ernst C, Martin M, Untch M, et al. Journal article, Letter BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2-Breast Cancer Treated with Endocrine Therapy with or Without Palbociclib: A Secondary PENELOPE-B Study Analysis (2025) Hahnen E, Hauke J, Gelmon K, Marmé F, Ernst C, Martin M, Untch M, et al. Journal article Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping (2025) Denkert C, Rachakonda S, Karn T, Weber K, Martin M, Marmé F, Untch M, et al. Journal article Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group (2025) Katsivelos N, Spyrou N, Weber D, Vasova I, Ayuk F, Choe H, Hogan W, et al. Journal article